The Globe and Mail: Former cannabis executives betting psychedelic drugs could be the next big thing


Former cannabis executives betting psychedelic drugs could be the next big thing 

“There’s a lot of untapped value in psychedelic substances because they’re [illegal],” said JR Rahn, founder of Toronto-based MindMed, which counts Canopy founder Bruce Linton and Shark Tank star Kevin O’Leary among its early investors.